- Status:
- Red
- Decision Date:
- November 2023
Comments
RED:
NICE TA925 for treating moderately to severe active ulcerative colitis. ICB commissioned (Decision date - November 2023)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again